ER β Antibodies

Santa Cruz Biotechnology offers a broad range of ER β Antibodies for research focused on understanding estrogen receptor beta signaling pathways. ER β Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Estrogen receptor beta plays a crucial role in mediating the effects of estrogen in various tissues, influencing processes such as cell proliferation, differentiation, and apoptosis. ER β signaling significantly impacts reproductive health and bone density regulation, with important implications for cancer biology research. Understanding ER β mechanisms provides essential knowledge about hormone-dependent cellular responses and their regulation in normal physiology. Investigating ER β pathways helps reveal potential therapeutic targets for hormone-related disorders and cancers. Research with ER β can advance our understanding of tissue-specific estrogen responses and their role in development and disease. Santa Cruz Biotechnology monoclonal antibodies for ER β support researchers worldwide in advancing scientific knowledge of estrogen signaling pathways and their impact on human health.